| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 21 |
| 1 | CITALOPRAM | 19 |
| 2 | CITALOPRAM HYDROBROMIDE | 19 |
| 3 | OCRELIZUMAB | 18 |
| 4 | VALSARTAN | 16 |
| 5 | VALSARTAN ORAL | 16 |
| 6 | ADALIMUMAB | 15 |
| 7 | CLARITHROMYCIN | 15 |
| 8 | CANDESARTAN | 14 |
| 9 | DICLOFENAC SODIUM | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAMPHOR, CAPSAICIN, MENTHOL | 2 | 0.0038 |
| 1 | MENTHOL, UNSPECIFIED FORM | 2 | 0.0032 |
| 2 | BEPOTASTINE BESILATE | 2 | 0.0031 |
| 3 | BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE | 1 | 0.0025 |
| 4 | HYDROQUINONE | 1 | 0.0017 |
| 5 | CUPRIC CHLORIDE | 1 | 0.0013 |
| 6 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 7 | 0.0011 |
| 7 | ECALLANTIDE | 2 | 0.0011 |
| 8 | DARUNAVIR 600 MG | 6 | 0.0010 |
| 9 | LAMIVUDINE AND ZIDOVUDINE | 7 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 31 |
| 1 | Progestin [EPC] | 25 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 23 |
| 3 | GLP-1 Receptor Agonist [EPC] | 21 |
| 4 | Progestin-containing Intrauterine System [EPC] | 21 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 19 |
| 6 | Corticosteroid [EPC] | 19 |
| 7 | Serotonin Reuptake Inhibitor [EPC] | 18 |
| 8 | Proton Pump Inhibitor [EPC] | 17 |
| 9 | Estrogen [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 1 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 2 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 7 | 0.0007 |
| 4 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 8 | 0.0005 |
| 5 | Gonadotropin [EPC] | 1 | 0.0005 |
| 6 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 7 | Macrolide Antimicrobial [EPC] | 15 | 0.0003 |
| 8 | General Anesthetic [EPC] | 12 | 0.0003 |
| 9 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |